Peer Review reports
From: Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
| Original Submission | ||
|---|---|---|
| 21 Apr 2023 | Submitted | Original manuscript |
| 11 Jun 2023 | Reviewed | Reviewer Report |
| 3 Jul 2023 | Reviewed | Reviewer Report |
| 17 Jul 2023 | Author responded | Author comments - Kenji Ikezawa |
| Resubmission - Version 2 | ||
| 17 Jul 2023 | Submitted | Manuscript version 2 |
| 19 Jul 2023 | Author responded | Author comments - Kenji Ikezawa |
| Resubmission - Version 3 | ||
| 19 Jul 2023 | Submitted | Manuscript version 3 |
| Publishing | ||
| 21 Jul 2023 | Editorially accepted | |
| 31 Jul 2023 | Article published | 10.1186/s12885-023-11205-6 |
You can find further information about peer review here.